Cowen Healthcare Completes Cetrotide Acquisition

AEterna Zentaris Inc. (Nasdaq: AEZS) has completed the previously-announced sale of its rights to royalties on future sales of Cetrotide to Cowen Healthcare Royalty Partners. The deal is valued at $52.5 million, plus another $2.5 million in possible earnouts. Cetrotide is a treatment for in virto fertilization.

DealsNorth AmericaUSBriefs